See today's BioWorld
To read the full story, subscribe or sign in.

Manufacturers to foot much of the bill for Medicare insulin savings

May 26, 2020
By Mari Serebrov
Unpredictable and unaffordable copays for insulin could be a thing of the past for millions of people enrolled in certain Medicare Part D prescription drug plans.
BioWorld Drugs Regulatory U.S. CMS